GenMark Diagnostics, Inc.
(NASDAQ : GNMK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. 0.98%163.090.7%$520.18m
MDTMedtronic Plc 0.13%119.010.6%$396.86m
ABTAbbott Laboratories 0.83%89.010.8%$362.86m
ISRGIntuitive Surgical, Inc. 0.29%600.032.4%$362.07m
TMOThermo Fisher Scientific, Inc. 0.71%339.141.0%$288.79m
BSXBoston Scientific Corp. 2.50%44.281.1%$284.80m
BDXBecton, Dickinson & Co. 0.08%277.091.1%$261.39m
SYKStryker Corp. 1.25%212.081.3%$248.97m
ABMDABIOMED, Inc. -0.09%181.283.3%$209.66m
EWEdwards Lifesciences Corp. -0.05%238.461.2%$209.38m
BAXBaxter International, Inc. -0.29%89.731.8%$205.14m
ALGNAlign Technology, Inc. -1.52%280.706.4%$195.31m
STESTERIS Plc (Ireland) -0.06%154.043.7%$171.56m
DXCMDexCom, Inc. -1.54%230.798.3%$168.83m
NVSTEnvista Holdings Corp. 0.25%32.020.0%$142.47m

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the provision of multiplex molecular diagnostic solutions. Its products include ePlex and XT-8. The company was founded by Jon Faiz Kayyemin 1993 and is headquartered in Carlsbad, CA.